Mitchell G. Lawrence

4.7k citations

54 papers · 2.4k · 1 hit paper · h-index 24

Impact in

Cancer Research top 5%
Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema

Papers in

Pulmonary and Respiratory Medicine 32
- Prostate Cancer Treatment and Research 31
Molecular Biology 22
- Epigenetics and DNA Methylation 6
- Protein Degradation and Inhibitors 4
- RNA modifications and cancer 4

Co-authors: Gail P. Risbridger (35 shared papers)Judith A. Clements (12 shared papers)Susan J. Clark (4 shared papers)Clare Stirzaker (4 shared papers)Elena Zotenko (2 shared papers)Ruth Pidsley (3 shared papers)Timothy J. Peters (1 shared paper)Beverly S. Mühlhäusler (1 shared paper)
Journals: Clinical Epigenetics (2 papers)The Prostate (2 papers)Biological Chemistry (2 papers)The Journal of Pathology (2 papers)Endocrine Related Cancer (2 papers)
Partner nations: Australia United States Canada

In The Last Decade

Mitchell G. Lawrence

53 papers receiving 2.4k citations

Mitchell G. Lawrence's Hit Papers

align trajectories log scale

Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling 2016 · 832 citations

Peers

Countries citing papers authored by Mitchell G. Lawrence

Since Specialization

Citations

This map shows the geographic impact of Mitchell G. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell G. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell G. Lawrence more than expected).

Fields of papers citing papers by Mitchell G. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell G. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell G. Lawrence. The network helps show where Mitchell G. Lawrence may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell G. Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell G. Lawrence Line = papers co-authored together Mitchell G. Lawrence links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling Genome biology ·Ruth Pidsley, Elena Zotenko, Timothy J. Peters, Mitchell G. Lawrence, Gail P. Risbridger, Peter L. Molloy, Susan Van Djik, Beverly S. Mühlhäusler, Clare Stirzaker, Susan J. Clark Hit paper breakdown →	2016	832
2	Kallikreins on Steroids: Structure, Function, and Hormonal Regulation of Prostate-Specific Antigen and the Extended Kallikrein Locus Endocrine Reviews ·Mitchell G. Lawrence, John Lai, Judith A. Clements	2010	193
3	Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells Endocrine Related Cancer ·Tara Veveris‐Lowe, Mitchell G. Lawrence, Rachael Collard, Laura Bui, Adrian C. Herington, Dianne Nicol, Judith A. Clements	2005	128
4	Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis European Urology ·Gail P. Risbridger, Renea A. Taylor, David Clouston, Ania Sliwinski, Heather Thorne, Sally M. Hunter, Jason Li, Gillian Mitchell, Declan G. Murphy, Mark Frydenberg, David Pook, J.K. Pedersen, Roxanne Toivanen, Hong Wang, Melissa Papargiris, Mitchell G. Lawrence, Damien Bolton	2014	96
5	Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells The Prostate ·Mitchell G. Lawrence, Naira V. Margaryan, Daniela Loessner, Angus Collins, Kris Kerr, Megan Turner, Elisabeth A. Seftor, Carson Stephens, John Lai, (unknown), Lynne‐Marie Postovit, Judith A. Clements, Mary J.C. Hendrix	2011	87
6	Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment Molecular & Cellular Proteomics ·Elizabeth V. Nguyen, Brooke Pereira, Mitchell G. Lawrence, Xiuquan Ma, Richard J. Rebello, Howard Chan, Birunthi Niranjan, Yunjian Wu, Stuart J. Ellem, Xiaoqing Guan, Jianmin Wu, Joanna N. Skhinas, Thomas R. Cox, Gail P. Risbridger, Renea A. Taylor, Natalie L. Lister, Roger J. Daly	2019	77
7	A preclinical xenograft model of prostate cancer using human tumors Nature Protocols ·Mitchell G. Lawrence, Renea A. Taylor, Roxanne Toivanen, John Pedersen, Sam Norden, David Pook, Mark Frydenberg, (unknown), Melissa Papargiris, Birunthi Niranjan, Michelle G. Richards, Hong Wang, Anne T. Collins, Norman J. Maitland, Gail P. Risbridger	2013	75
8	Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories European Urology ·Laura H. Porter, Mitchell G. Lawrence, Dragan Ilić, David Clouston, Damien Bolton, Mark Frydenberg, Declan G. Murphy, Carmel Pezaro, Gail P. Risbridger, Renea A. Taylor	2017	72
9	A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer Biomaterials ·Ashlee K. Clark, Anna Taubenberger, Renea A. Taylor, Birunthi Niranjan, Zhen Y. Chea, Elena Zotenko, Shirly Sieh, John S. Pedersen, Sam Norden, Mark Frydenberg, Jeremy Grummet, David Pook, Clare Stirzaker, Susan J. Clark, Mitchell G. Lawrence, Stuart J. Ellem, Dietmar W. Hutmacher, Gail P. Risbridger	2013	52
10	Cancer Plasticity: The Role of mRNA Translation Trends in cancer ·Laura Lee, David Papadopoli, Michael Jewer, Sonia V. del Rincón, Ivan Topisirović, Mitchell G. Lawrence, Lynne‐Marie Postovit	2020	50
11	High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids SLAS DISCOVERY ·Nicholas Choo, Susanne Ramm, Jennii Luu, Jean M. Winter, Luke A. Selth, Amy R. Dwyer, Mark Frydenberg, Jeremy Grummet, Shahneen Sandhu, Theresa E. Hickey, Wayne D. Tilley, Renea A. Taylor, Gail P. Risbridger, Mitchell G. Lawrence, Kaylene J. Simpson	2021	46
12	Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression Journal of Cellular Physiology ·Honor J. Hugo, Leigh Ackland, Tony Blick, Mitchell G. Lawrence, Judith A. Clements, Elizabeth D. Williams, Erik W. Thompson	2007	45
13	Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro Biomaterials ·Brooke Pereira, Natalie L. Lister, Kohei Hashimoto, Linda Teng, María Flandes‐Iparraguirre, Angelina Eder, Alvaro Sánchez‐Herrero, Birunthi Niranjan, Mark Frydenberg, Melissa Papargiris, Mitchell G. Lawrence, Renea A. Taylor, Dietmar W. Hutmacher, Stuart J. Ellem, Gail P. Risbridger, Elena M. De‐Juan‐Pardo	2019	43
14	Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity Oncotarget ·Itsuhiro Takizawa, Mitchell G. Lawrence, Preetika Balanathan, Richard J. Rebello, Helen Pearson, Elika Garg, John Pedersen, Normand Pouliot, Robert Nadon, Matthew J. Watt, Renea A. Taylor, Patrick O. Humbert, Ivan Topisirović, Ola Larsson, Gail P. Risbridger, Luc Furic	2014	43
15	Bone Morphogenetic Proteins: Biology, Biochemistry and Reconstructive Surgery. Journal of Bone and Joint Surgery - British Volume ·Mitchell G. Lawrence	1996	35
16	Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate‐tolerant cells British Journal of Urology ·Laura H. Porter, Kohei Hashimoto, Mitchell G. Lawrence, Carmel Pezaro, David Clouston, Hong Wang, Melissa Papargiris, Heather Thorne, Jason Li, (unknown), Anthony J. Ryan, Sam Norden, Daniel Moon, Damien Bolton, Shomik Sengupta, Mark Frydenberg, Declan G. Murphy, Gail P. Risbridger, Renea A. Taylor	2017	33
17	Estrogen Receptor β Activation Impairs Prostatic Regeneration by Inducing Apoptosis in Murine and Human Stem/Progenitor Enriched Cell Populations PLoS ONE ·Shirin Hussain, Mitchell G. Lawrence, Renea A. Taylor, Camden Lo, A. P. C. BioResource, Mark Frydenberg, Stuart J. Ellem, Luc Furic, Gail P. Risbridger	2012	32
18	A variant of the KLK4 gene is expressed as a cis sense–antisense chimeric transcript in prostate cancer cells RNA ·John Lai, Melanie Lehman, Marcel E. Dinger, Stephen C. Hendy, Tim R. Mercer, Inge Seim, Mitchell G. Lawrence, John S. Mattick, Judith A. Clements, Colleen C. Nelson	2010	30
19	Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer Frontiers in Oncology ·Daisuke Obinata, Mitchell G. Lawrence, Ken‐ichi Takayama, Nicholas Choo, Gail P. Risbridger, Satoru Takahashi, Satoshi Inoue	2020	30
20	Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer The Prostate ·Mitchell G. Lawrence, David Pook, Hong Wang, Laura H. Porter, Mark Frydenberg, John Kourambas, Sree Appu, Christine Poole, Emma K. Beardsley, Andrew Ryan, Sam Norden, Melissa Papargiris, Gail P. Risbridger, Renea A. Taylor	2015	29

About Mitchell G. Lawrence

Mitchell G. Lawrence is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 54 papers that have together received 2.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (31 papers), Cancer Cells and Metastasis (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Epigenetics and DNA Methylation (6 papers), Protein Degradation and Inhibitors (4 papers), Cancer Genomics and Diagnostics (4 papers), RNA modifications and cancer (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Cancer Research (469 citations), Genetics (237 citations), Pulmonary and Respiratory Medicine (704 citations), Oncology (565 citations) and Molecular Biology (1.4k citations). Mitchell G. Lawrence has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Gail P. Risbridger, Judith A. Clements, Susan J. Clark, Clare Stirzaker, Elena Zotenko, Ruth Pidsley, Timothy J. Peters, Beverly S. Mühlhäusler, Peter L. Molloy and Susan Van Djik. Their work appears in journals such as Clinical Epigenetics, The Prostate, Biological Chemistry, The Journal of Pathology and Endocrine Related Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mitchell G. Lawrence

Impact in

Papers in i

In The Last Decade

Mitchell G. Lawrence

Mitchell G. Lawrence's Hit Papers

Peers

Countries citing papers authored by Mitchell G. Lawrence

Fields of papers citing papers by Mitchell G. Lawrence

All Works

About Mitchell G. Lawrence

Explore authors with similar magnitude of impact

Papers in